1. Home
  2. SYRE vs AVAH Comparison

SYRE vs AVAH Comparison

Compare SYRE & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRE
  • AVAH
  • Stock Information
  • Founded
  • SYRE 2013
  • AVAH 1984
  • Country
  • SYRE United States
  • AVAH United States
  • Employees
  • SYRE N/A
  • AVAH N/A
  • Industry
  • SYRE Biotechnology: Pharmaceutical Preparations
  • AVAH Hospital/Nursing Management
  • Sector
  • SYRE Health Care
  • AVAH Health Care
  • Exchange
  • SYRE Nasdaq
  • AVAH Nasdaq
  • Market Cap
  • SYRE 1.2B
  • AVAH 1.0B
  • IPO Year
  • SYRE 2016
  • AVAH 2021
  • Fundamental
  • Price
  • SYRE $16.14
  • AVAH $5.42
  • Analyst Decision
  • SYRE Strong Buy
  • AVAH Hold
  • Analyst Count
  • SYRE 8
  • AVAH 4
  • Target Price
  • SYRE $51.50
  • AVAH $4.94
  • AVG Volume (30 Days)
  • SYRE 661.8K
  • AVAH 420.0K
  • Earning Date
  • SYRE 05-08-2025
  • AVAH 03-13-2025
  • Dividend Yield
  • SYRE N/A
  • AVAH N/A
  • EPS Growth
  • SYRE N/A
  • AVAH N/A
  • EPS
  • SYRE N/A
  • AVAH N/A
  • Revenue
  • SYRE N/A
  • AVAH $2,024,506,000.00
  • Revenue This Year
  • SYRE N/A
  • AVAH $6.10
  • Revenue Next Year
  • SYRE N/A
  • AVAH $5.12
  • P/E Ratio
  • SYRE N/A
  • AVAH N/A
  • Revenue Growth
  • SYRE N/A
  • AVAH 6.82
  • 52 Week Low
  • SYRE $16.13
  • AVAH $2.11
  • 52 Week High
  • SYRE $40.84
  • AVAH $6.19
  • Technical
  • Relative Strength Index (RSI)
  • SYRE 35.24
  • AVAH 60.10
  • Support Level
  • SYRE $16.71
  • AVAH $5.28
  • Resistance Level
  • SYRE $18.28
  • AVAH $5.69
  • Average True Range (ATR)
  • SYRE 1.21
  • AVAH 0.34
  • MACD
  • SYRE -0.03
  • AVAH 0.05
  • Stochastic Oscillator
  • SYRE 0.15
  • AVAH 86.48

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About AVAH Aveanna Healthcare Holdings Inc.

Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.

Share on Social Networks: